Trials / Conditions / DS Stage III Multiple Myeloma
DS Stage III Multiple Myeloma
3 registered clinical trials studyying DS Stage III Multiple Myeloma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multi NCT00644228 | National Cancer Institute (NCI) | Phase 3 |
| Active Not Recruiting | Lenalidomide in Treating Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant NCT00114101 | National Cancer Institute (NCI) | Phase 3 |
| Active Not Recruiting | Lenalidomide and Dexamethasone With or Without Thalidomide in Treating Patients With Multiple Myeloma NCT00098475 | National Cancer Institute (NCI) | Phase 3 |